Ticker: GSK CUSIP: 37733W204 Class: SPONSORED ADR
Note: Option positions (PUT/CALL) are excluded.
| Period | Shares | Value ($000) | Average Close | Price Range |
|---|---|---|---|---|
| Q4 2025 | 5,828,663 | $285,838 | — | — |
| Q3 2025 | 4,949,228 | $213,609 | — | — |
| Q2 2025 | 5,174,255 | $198,692 | — | — |
| Q1 2025 | 5,315,522 | $205,923 | — | — |
| Q4 2024 | 5,726,994 | $193,687 | — | — |
| Q3 2024 | 7,953,833 | $325,153 | — | — |
| Q2 2024 | 10,108,519 | $389,178 | — | — |
| Q1 2024 | 12,471,037 | $534,633 | — | — |
| Q4 2023 | 8,552,173 | $316,944 | — | — |
| Q3 2023 | 7,551,555 | $273,744 | — | — |
| Q2 2023 | 7,395,075 | $263,561 | — | — |
| Q1 2023 | 5,606,100 | $199,465 | — | — |
| Q4 2022 | 5,106,194 | $179,432 | — | — |
| Q3 2022 | 5,031,049 | $148,063 | — | — |